Clinical Trial

Etomidate and Esketamine on Postoperative Pain After Tonsillectomy Undergoing Children

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated November 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Objective: To explore the effect of etomidate and esketamine on postoperative pain after tonsillectomy in children. Methods: Investigators enrolled 64 children with American Society of Anesthesiologists (ASA) physical status I and II, aged 2-10 years, and scheduled for elective undergoing tonsillectomy with general anesthesia. All the enrolled patients were randomly divided into etomidate and fentanyl group (Group A) and etomidate and esketamine group (Group B). In the etomidate-fentanyl group (group A), 0.3 mg/kg etomidate and 4 µg/kg fentanyl were given at the induction of anesthesia, followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the surgery, respectively; in the etomidate-esketamine group (group B), induction of anesthesia with 0.3 mg/kg etomidate and 0.5 mg/kg esketamine , followed by continuous infusion of propofol at 4-12 mg/kg/h and remifentanil at 3-6 µg/kg/h until the end of the operation. Anesthesiologists who were unaware of the grouping recorded the FlACC Pain Scale at 2 h, 8 h, and 24 h after surgery.
Trial Details
NCT Number NCT07062601
Lead Sponsor Anqing Municipal Hospital
Conditions Etomidate, Esketamine, Tonsillectomy, Children
Enrollment 64 participants
Start Date 2025-07-10
Primary Completion 2025-11-10 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-14